Clinical trial
A Study to Determine Whether Epoetin Alfa Can Reduce the Need for Blood…
NCT00270088 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Completed
Key facts
| NCT number | NCT00270088 |
|---|---|
| Title | A Study to Determine Whether Epoetin Alfa Can Reduce the Need for Blood Transfusions in Patients During the Period of Time Around Major Orthopedic Surgery. |
| Official title | A Double-Blind, Placebo-Controlled Study to Determine Whether Procrit (Epoetin Alfa) Can Reduce Peri-Operative Transfusion Requirements in Subjects Undergoing Major Orthopedic Surgery |
| Lead sponsor | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia, Blood Transfusion, Orthopedic Procedures |
| Intervention type | Drug |
| Interventions | epoetin alfa |
| Enrollment | 316 |
| Start date | Apr 1, 1993 |
| Completion | Aug 1, 1994 |
| First posted | Dec 26, 2005 |
| Last update posted | May 18, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: